)
Moberg Pharma (MOB) investor relations material
Moberg Pharma Stora Aktiedagarna 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Product innovation and clinical results
Developed a topical terbinafine-based treatment for nail fungus, achieving up to 40x higher concentration in the nail bed and 1,000x lower systemic exposure compared to oral tablets, delivering the gold standard antifungal directly to the nail.
Achieved a 76% mycological cure rate in clinical studies with over 800 patients, matching oral treatments and outperforming other topical and OTC options globally, which typically have cure rates around 20%.
Product offers a favorable safety profile, rapid visible improvement, ease of application, and supports patient adherence, as confirmed by patient surveys.
75% of patients reported improvement after 12 weeks, supporting premium pricing at SEK 399 in Sweden.
Nail fungus is chronic, with a 50% reinfection risk within two years and a prevalence of 10% in the population, affecting over 70 million Europeans.
Market performance and expansion
Achieved market leadership in Sweden and Norway within two years, with 42% value share in Sweden and 34% in Norway, driving category growth and significant value and volume shares.
Approved in 13 European countries with ongoing rollout and additional approvals in the pipeline.
Product recognized as launch of the year by major pharmacy chains in Sweden and nominated in Norway, indicating strong market acceptance and revitalization of the category.
Four commercial partners secured, including Karo Healthcare, enabling broad European distribution under the Lamisil brand and partnerships for Europe, Canada, Scandinavia, and Israel.
U.S., China, Japan, and Southeast Asia identified as key future markets, with the U.S. prioritized for direct brand control.
Market opportunity and growth drivers
Global onychomycosis market estimated at $2 billion, with growth driven by high prevalence, aging population, lifestyle factors, and rising awareness.
Many doctors avoid prescribing oral terbinafine due to side effects, increasing demand for effective topical alternatives.
The product expands the market by converting non-treaters and dissatisfied users, unlocking further growth potential.
Next Moberg Pharma earnings date
Next Moberg Pharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)